Clinical trial
ASSET (Acupil® Non Interventional Study For Evaluation Of Safety Effectiveness And Tolerability)
NCT00930722 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ASSET (Acupil® Non Interventional Study For Evaluation Of Safety Effectiveness And Tolerability)
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2009
- Completion date
- June 30, 2010
- Enrollment
- 329 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.